RXO’s (RXO) Hold Rating Reaffirmed at Benchmark

RXO (NYSE:RXOGet Free Report)‘s stock had its “hold” rating reiterated by analysts at Benchmark in a report released on Tuesday, Benzinga reports.

A number of other equities analysts also recently weighed in on RXO. UBS Group increased their price objective on RXO from $22.00 to $31.00 and gave the stock a “neutral” rating in a report on Thursday, August 8th. Oppenheimer raised their price target on RXO from $22.00 to $31.00 and gave the stock an “outperform” rating in a research note on Thursday, August 8th. JPMorgan Chase & Co. lifted their price target on RXO from $25.00 to $26.00 and gave the company an “underweight” rating in a report on Thursday, August 8th. TD Cowen increased their price objective on RXO from $23.00 to $28.00 and gave the stock a “hold” rating in a report on Thursday, August 8th. Finally, Stephens reiterated an “equal weight” rating and issued a $22.00 target price on shares of RXO in a research note on Monday, May 6th. Two equities research analysts have rated the stock with a sell rating, nine have assigned a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat, RXO presently has a consensus rating of “Hold” and an average price target of $25.18.

Read Our Latest Report on RXO

RXO Stock Down 3.2 %

RXO stock traded down $0.89 during mid-day trading on Tuesday, hitting $27.24. The company’s stock had a trading volume of 107,209 shares, compared to its average volume of 703,501. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.14 and a quick ratio of 1.14. RXO has a 52-week low of $16.94 and a 52-week high of $32.82. The firm’s 50 day moving average is $26.19 and its 200 day moving average is $22.66. The company has a market cap of $3.20 billion, a PE ratio of -302.89, a price-to-earnings-growth ratio of 5.60 and a beta of 1.38.

RXO (NYSE:RXOGet Free Report) last announced its quarterly earnings data on Wednesday, August 7th. The company reported $0.03 EPS for the quarter, meeting analysts’ consensus estimates of $0.03. RXO had a negative net margin of 0.29% and a positive return on equity of 3.23%. The firm had revenue of $930.00 million for the quarter, compared to the consensus estimate of $934.14 million. During the same period in the previous year, the firm posted $0.08 earnings per share. The firm’s revenue was down 3.4% on a year-over-year basis. On average, analysts anticipate that RXO will post 0.17 earnings per share for the current year.

Institutional Trading of RXO

Several large investors have recently modified their holdings of RXO. GAMMA Investing LLC bought a new position in RXO in the 4th quarter worth $27,000. Motco increased its stake in shares of RXO by 5,450.0% in the first quarter. Motco now owns 2,442 shares of the company’s stock worth $53,000 after purchasing an additional 2,398 shares during the period. TFO Wealth Partners LLC lifted its position in shares of RXO by 106,833.3% during the 4th quarter. TFO Wealth Partners LLC now owns 3,208 shares of the company’s stock worth $70,000 after purchasing an additional 3,205 shares during the last quarter. Allspring Global Investments Holdings LLC lifted its position in shares of RXO by 2,235.3% during the 1st quarter. Allspring Global Investments Holdings LLC now owns 3,643 shares of the company’s stock worth $80,000 after purchasing an additional 3,487 shares during the last quarter. Finally, Canada Pension Plan Investment Board bought a new stake in RXO during the 2nd quarter valued at approximately $112,000. 92.73% of the stock is owned by institutional investors.

About RXO

(Get Free Report)

RXO, Inc provides full truckload freight transportation brokering services. It also offers brokered services for managed transportation, last mile, and freight forwarding. The company was incorporated in 2022 and is based in Charlotte, North Carolina.

Read More

Analyst Recommendations for RXO (NYSE:RXO)

Receive News & Ratings for RXO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RXO and related companies with MarketBeat.com's FREE daily email newsletter.